Metabolic and neuromodulatory basis of altered activated and deactivated cortical areas in healthy human aging
Metabolic and neuromodulatory basis of altered activated and deactivated cortical areas in healthy human aging
批准号:
10647162
负责人:
Dewan Syed Fahmeed Hyder
金额:
$65.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-01 至 2024-07-31
关键词:
AddressAgeAgingAreaBiological MarkersBrainBrain regionCell RespirationCitric Acid CycleCognitionDevelopmentElderlyFinancial compensationFunctional Magnetic Resonance ImagingGasesGlutamatesHealthHumanImageInhalationMagnetic Resonance ImagingMeasurementMeasuresMetabolicMethodsMitochondriaNeuronsPhysiologicalRestRoleSensoryTestingVisualVisual CortexWorkagedaging braincingulate cortexgamma-Aminobutyric Acidhealthy agingloss of functionmemory processmultimodalityneuroregulationnovelnovel therapeuticspatient populationresponsetargeted treatmenttheories
中文摘要
项目总结/文摘
英文摘要
Project Summary/Abstract
Human healthy aging is associated with declines in cognition, memory, and processing efficiency. Two
leading theories to explain altered function are the mitochondrial theory of aging, in which mitochondria lose
the ability to provide sufficient energy to support function and altered GABA/glutamate neuromodulation.
Recent developments in calibrated functional MRI (fMRI) have allowed direct imaging of alterations in neuronal
activity in aging. Surprisingly, measurements of task-induced changes in oxidative metabolism (ΔCMRO2) have
found increased neuronal activation despite lower baseline CMRO2 in aging.
We propose to address this paradox, by using a novel combination of calibrated fMRI, functional 1H-MRS
(fMRS), and 1H[13C]-MRS approach to directly test the roles of mitochondrial aging and neuromodulation in
healthy aging. Our general hypotheses are: (i) The paradoxical increased functional response in healthy
aging, observed primarily in sensory areas, is a compensation for lower baseline CMRO2, but it is not sufficient
to achieve the same energetic support for neuronal function as in young subjects (mitochondrial aging theory);
and (ii) The inverse relationship between GABA concentration and BOLD activation established in young
subjects is blunted in elderly (neuromodulation theory). We will test these hypotheses with three specific aims.
In Aim 1 we will use a novel gas-free calibrated fMRI method to measure ΔCMRO2 in response to visual
task in healthy young and aged subjects. In Aim 2 we will perform, in parallel with calibrated fMRI, fMRS
measurements of inhibitory GABA and excitatory glutamate. In Aim 3 we will use 1H[13C]-MRS to specifically
measure neuronal CMRO2 (via the TCA cycle) which we showed is selectively decreased in aging visual cortex.
In parallel with our testing of changes in activated brain regions like the visual cortex, we will also perform
the same measurements simultaneously in the posterior cingulate cortex (PCC), which is a major hub of the
default mode network (DMN) that has been shown to deactivate during tasks. Resting-state fMRI studies in
aging have shown that the DMN connectivity is altered, but there have been no studies looking at its task
response using quantitative fMRI or fMRS methods. Understanding the metabolic and neuromodulatory
differences across activated and deactivated areas are crucial for understanding the basis of the altered
functional response in healthy aging. The proposed work has high potential human health significance both
for understanding basic mechanisms behind the alterations in neuronal activity in aging and in validating a
novel multi-modal MRI/MRS biomarker for evaluating these mechanisms and potentially assessing the
response to mechanism targeted therapeutics. Although 1H[13C]-MRS is not yet broadly available, we will
evaluate whether neuronal CMRO2 at rest determined from calibrated fMRI provides similar results. Because
the calibrated fMRI method does not require gas inhalation, it is broadly applicable to patient populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Acquisition of a Bruker 11.7T/16cm Preclinical Scanner for Novel MRI/MRSI Studies
-
批准号:10630511
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2023
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Interleaved 1H/23Na imaging for invasive and proliferative phenotypes of brain tumors
-
批准号:10634269
-
项目类别:
-
资助金额:$57.29万
-
财政年份:2023
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Hypoxia and pH Responsive Nanoparticles for Targeted Drug Delivery to Ischemic Stroke
-
批准号:10681846
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2023
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Delayed white matter loss in concussive head injuries and its treatment
-
批准号:10532800
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2021
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Delayed white matter loss in concussive head injuries and its treatment
-
批准号:10354469
-
项目类别:
-
资助金额:$25.53万
-
财政年份:2021
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
MRS validation of computational metabolic modeling of human brain function to determine energetic disruptions underlying fMRI-derived functional connectivity in degenerative or psychiatric disorders
-
批准号:9246003
-
项目类别:
-
资助金额:$19.89万
-
财政年份:2017
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Multivalent PARACEST agents for quantitative molecular imaging
-
批准号:8470166
-
项目类别:
-
资助金额:$30.06万
-
财政年份:2010
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Translation of smart contrast agents for brain tumor characterization by MR
-
批准号:8408792
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2010
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Multivalent PARACEST agents for quantitative molecular imaging
-
批准号:8101171
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2010
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Multivalent PARACEST agents for quantitative molecular imaging
-
批准号:8281539
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2010
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Translation of smart contrast agents for brain tumor characterization by MR
-
批准号:8105088
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2010
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Translation of smart contrast agents for brain tumor characterization by MR
-
批准号:8597534
-
项目类别:
-
资助金额:$33.83万
-
财政年份:2010
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Multivalent PARACEST agents for quantitative molecular imaging
-
批准号:7934868
-
项目类别:
-
资助金额:$35.08万
-
财政年份:2010
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Translation of smart contrast agents for brain tumor characterization by MR
-
批准号:8206633
-
项目类别:
-
资助金额:$35.02万
-
财政年份:2010
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Translation of smart contrast agents for brain tumor characterization by MR
-
批准号:7985170
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2010
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Core Center for Quantitative Neuroscience with Magnetic Resonance (QNMR)
-
批准号:7433705
-
项目类别:
-
资助金额:$65.95万
-
财政年份:2007
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Neurophysiologic
-
批准号:8788729
-
项目类别:
-
资助金额:$14.36万
-
财政年份:2007
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Core Center for Quantitative Neuroscience with Magnetic Resonance (QNMR)
-
批准号:8662879
-
项目类别:
-
资助金额:$64.83万
-
财政年份:2007
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Core Center for Quantitative Neuroscience with Magnetic Resonance (QNMR)
-
批准号:7250411
-
项目类别:
-
资助金额:$69.22万
-
财政年份:2007
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
Core Center for Quantitative Neuroscience with magnetic Resonance (QNMR)
-
批准号:7434775
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2007
-
负责人:Dewan Syed Fahmeed Hyder
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: